Neal

About Neal Evan Caminsky

This author has not yet filled in any details.
So far Neal Evan Caminsky has created 328 blog entries.

11 06, 2024

SARS-CoV-2 live virus neutralization after four COVID-19 doses in people with HIV receiving immunosuppressive antiretroviral therapy

Neal Evan Caminsky2024-06-11T12:21:48-04:00June 11, 2024|Funded Research Results, Pillar 1|

3 06, 2024

Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping combined with genome sequence analysis

Neal Evan Caminsky2024-06-03T09:48:41-04:00June 3, 2024|Funded Research Results, Pillar 6|

23 05, 2024

The RNA interference effector protein Argonaute 2 functions as a restriction factor against SARS-CoV-2

Neal Evan Caminsky2024-05-23T08:58:58-04:00May 23, 2024|Funded Research Results, Pillar 4|

22 05, 2024

The Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology

Neal Evan Caminsky2024-05-22T14:52:11-04:00May 22, 2024|Funded Research Results, Pillar 6|

22 05, 2024

Estimating SARS-CoV-2 seroprevalence in Canadian blood donors, April 2020 to March 2021: improving accuracy with multiple assays

Neal Evan Caminsky2024-05-22T13:39:08-04:00May 22, 2024|Funded Research Results, Pillar 4|

22 05, 2024

Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients

Neal Evan Caminsky2024-05-22T14:50:21-04:00May 22, 2024|Funded Research Results, Pillar 4|

22 05, 2024

SARS-CoV-2 virus-like particle neutralizing capacity in blood donors depends on serological profile and donor-declared SARS-CoV-2 vaccination history

Neal Evan Caminsky2024-05-22T10:26:15-04:00May 22, 2024|Funded Research Results, Pillar 4|

21 05, 2024

Neutralisation against Omicron variant in transplant recipients after three doses of mRNA vaccine

Neal Evan Caminsky2024-05-21T16:49:25-04:00May 21, 2024|Funded Research Results, Pillar 4|

21 05, 2024

Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings

Neal Evan Caminsky2024-05-21T14:35:38-04:00May 21, 2024|Funded Research Results, Pillar 4|

16 05, 2024

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B

Neal Evan Caminsky2024-05-16T09:19:07-04:00May 16, 2024|Funded Research Results, Pillar 4|